Managing anemia in HIV-positive women

Women's Health

Volumn 2, Issue 1, 2006, Pages 159-165

  O'Connell, Casey ^a   Levine, Alexandra M ^b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b NONE

Author keywords

AIDS; Anemia; HIV; Women

Indexed keywords

AMPHOTERICIN; ANTIFUNGAL AGENT; COTRIMOXAZOLE; FLUCYTOSINE; PLACEBO; RECOMBINANT ERYTHROPOIETIN; RIBAVIRIN; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AFRICAN AMERICAN; ANEMIA; CLINICAL PROTOCOL; CLINICAL TRIAL; DEMOGRAPHY; DRUG EFFICACY; DRUG SAFETY; ERYTHROCYTE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; MACROCYTIC ANEMIA; NONHUMAN; PATHOPHYSIOLOGY; PNEUMOCYSTIS PNEUMONIA; PREVALENCE; REVIEW; RISK FACTOR; STATISTICAL SIGNIFICANCE; SURVIVAL; VIRUS LOAD;

EID: 33646816050     PISSN: 17455057     EISSN: 17455065     Source Type: Journal    
DOI: 10.2217/17455057.2.1.159     Document Type: Review

References (27)

1. Sullivan PS, Hanson DL, Chu SY et al.: Epidemiology of anemia in human immunodeficiency virus infected persons: results from the Multistate Adult and Adolescent Spectrum of HIV Disease Surveillance Project. Blood 9l, 301-308 (1998).
2. Creagh T, Mildvan D: Greater prevalence of anemia in women and African Americans with HIV/AIDS in the HAART era: a study of 10,000 patients. The Anemia Prevalence Study Group. Program and Abstracts of the 40th Annual Meeting of the Infectious Dieases Society of America. Chicago, Alexandria, VA, USA: Infectious Diseases Society of America, 127 (2002) (Abstract 475).
3. Mocroft A, Kirk O, Barton SE et al.: Anemia is an independent predictive marker for clinical prognosis in HIV-infected patients from across Europe. EuroSIDA Study Group. AIDS 13, 943-950 (1999).
4. Levine AM, Berhane K, Masri-Lavine L et al.: Prevalence and correlates of anemia in a large cohort of HIV-infected women: Women's Interagency HIV Study. J. Acquir. Immune Defic. Syndr. 26, 28-35 (2001).
5. Semba RD, Shah N, Klein RS et al.: Prevalence and cumulative incidence of and risk factors for anemia in a multicenter cohort study of human immunodeficiency virus-infected and -uninfected women. Clin. Infect. Dis. 34, 260-266 (2002).
6. Saag MS, Bowers P, Leitz GJ, Levine AM: Once-weekly epoetin alfa improves quality of life and increases hemoglobin in anemic HIV+ patients. AIDS Res. Hum. Retroviruses 20, 1037-1045 (2004).
7. Grossman HA, Goon B, Bowers P, Leitz G and the 010 Study Group: Once-weekly epoetin alfa dosing is as effective as three times-weekly dosing in increasing hemoglobin levels and is associated with improved quality of life in anemic, HIV-infected patients. J. Acquir. Immune Defic. Syndr. 34, 368-378 (2003).
8. Revicki DA, Brown RE, Henry DH et al.: Recombinant human erythropoietin and health-related quality of life in AIDS patients with anemia. J. Acquir. Immune Defic. Syndr. 7, 474-484 (1994).
9. Berhane K, Karim R, Cohen MH et al.: Impact of highly active antiretroviral therapy on anemia and relationship between anemia and survival in a large cohort of HIV-infected women: Women's Interagency HIV Study. J. Acquir. Immune Defic. Syndr. 37, 1245-1252 (2004).
10. Volberding PA, Levine AM, Dieterich D et al.: Anemia in HIV infection: clinical impact and evidence-based management strategies. Clin. Infect. Dis. 38, 1454-1463 (2004).
11. Luther JM, Lakey DL, Larson RS et al.: Utility of bone marrow biopsy for rapid diagnosis of febrile illnesses in patients with human immunodeficiency virus infection. South. Med. J. 93, 692-697 (2000).
12. Semba RD, Shah N, Vlahov D: Improvement of anemia among HIV-infected injection drug users receiving highly active antiretroviral therapy. J. Acquir. Immune Defic. Syndr. 26, 315-319 (2001).
13. Moses AV, Williams S, Heneveld ML et al.: Human Immunodeficiency virus infection of bone marrow endothelium reduces induction of stromal hematopoietic growth factors. Blood 87, 919-925 (1996).
14. Bahner I, Kearns K, Coutinho S et al.: Infection of human marrow stroma by human immunodeficiency virus-1 (HIV-1) is both required and sufficienct for HIV-1-induced hematopoietic suppression in vitro: demonstration by gene modification of primary human stroma. Blood 90, 1787-1798 (1997).
15. Bagnara GP, Azuli G, Giovannini M et al.: Early loss of circulating hemopoietic progenitors in HIV-1-infected subjects. Exp. Hematol. 18, 426-430 (1990).
16. Spivak JL, Barnes DC, Fuchs PA, Quinn TC: Serum immunoreactive erythropoietin in HIV-infected patients. JAMA 261, 3104-3107 (1989).
17. Sipsas NV, Kokori SI, Ioannidis JP et al.: Circulating autoantibodies to erythropoietin are associated with human immunodeficiency virus type 1-related anemia. J. Infect. Dis. 180, 2044-2047 (1999).
18. Remacha AF, Cadafach J: Cobalamin deficiency in patients with the human immunodeficiency virus. Semin. Hematol. 36, 75-87 (1999).
19. Thompson CE, Damon LE, Lies CA, Linker CA: Thrombotic microangiopathies in the 1980's: clinical features, response to treatment, and the impact of the human immunodeficiency virus epidemic. Blood 80, 1890-1895 (1992).
20. Rarick MU, Espina B, Mochamuk R et al.: Thrombotic thrombocytopenic purpura in patients with human immunodeficiency virus infection: a report of three cases and review of the literature. Am. J. Hematol. 40, 103-109 (1992).
21. Sahud MA, Claster S, Liu L et al.: Von-Willebrand factor cleaving protease inhibitor in a patient with human immunodeficiency virus-associated thrombotic thrombocytopenic purpura. Br. J. Haematol. 116, 909-911 (2002).
22. Saif MW: HIV-associated autoimmune hemolytic anemia: an update. AIDS Patient Care STDs 15, 217-224 (2001).
23. Nunez M, Soriano V: Management of patients coinfected with hepatitis B virus and HIV. Lancet Infect. Dis. 5. 374-382 (2005).
24. Soriano V, Maida, I, Nunez M et al.: Long-term follow-up of HIV-infected patients with chronic hepatitis C virus infection treated with interferon-based therapies. Antivir. Ther. 9, 987-992 (2004).
25. Frederick RT, Hassanein TI: Role of growth factors in the treatment of patients with HIV/HCV coinfection and patients with recurrent hepatitis C following liver transplant. J. Clin. Gastroenterol. 39(Suppl. 1), S14-S22 (2005).
26. Fischl M, Galpin JE, Levine JD et al.: Recombinant human erythropoietin for patients with AIDS treated with zidovudine. N. Engl. J. Med. 322, 1488-1493 (1990).
27. Henry DH, Beall GN, Benson CA et al.: Recombinant human erythropoietin in the treatment of anemia associated with human immunodeficiency virus (HIV) infection and zidovudine therapy: overview of four clinical trials. Ann. Intern. Med. 1992, 739-748 (2002).